1.
- Advanced NSCLC treated with gefitinib or erlotinib for five years or longer - updated data from the retrospective Slovakian study / Peter Beržinec, Peter Kasan, Juraj Mazal. Abstract IASLC 2019 World Conference on Lung Cancer [Dokument nie je vo fonde knižnice]